AlphAIAlphAI — Financial news for AI agents
stocktitan.netOCT 61 min read$SNX

TD SYNNEX CEO disposes of 1,103 common shares

TD SYNNEX CEO disposed of 1,103 common shares on October 5, 2026, at $277.28 per share, according to an SEC filing. The CEO now holds 169,825 shares directly. This transaction is notable for investors tracking insider activity in the company.

Original reporting
stocktitan.net
Published Oct 6, 2026, 9:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 9:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$SNX
Bearish
medium confidence
Mentioned
$SNX
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SNXBearishLow
01

Why it matters

The sale is a primary disclosure; while the amount is modest, it provides fresh data for traders.

02

Market read

New insider sale information may influence short‑term sentiment and trading decisions.

03

Timing

after‑hours 10/05/2026 filing

Relevance 4/10Novelty 4/10Timing: after‑hours 10/05/2026 filing

Background

SEC Form 4 filing discloses a recent insider sale by TD SYNNEX's CEO.

Company-level read

Ticker impact

$SNXBearishMedium confidence
Context

CEO Cheryl Grant sold 1,103 common shares at $277.28 each, reducing her stake to 169,825 shares.

Expected impact

likely modest downward pressure as the market prices the insider sale

Evidence & confidence

A 1,103‑share sale (~$306k) by the CEO is a small but material insider transaction; traders may view it as a slight negative signal.

Key entities

  • Company
    TD SYNNEX Corp.

    Technology distribution company listed on NYSE under ticker SNX.

  • Executive
    Cheryl Grant

    CEO and director of TD SYNNEX, reporting the share disposition.

Read at source← All news

Related articles

OCT 7
$SNXMed

TD SYNNEX stock: BlueStar deal follows a cash-flow reversal

TD SYNNEX agreed to buy BlueStar, expanding its tech distribution. The deal lacks a disclosed price and awaits approvals. TD SYNNEX's latest quarter showed $416.2M net income but a $916.7M operating cash outflow, raising cash-flow concerns. Shares fell 2.46% on Oct 7. BlueStar's addition could broaden offerings, but financial details are unclear.

techi.com3 min
OCT 7
$TDMed

TD SYNNEX Adding Specialty Technology Distributor BlueStar

TD SYNNEX agreed to acquire BlueStar, a specialty tech distributor, to expand its offerings. BlueStar focuses on tech like RFID and robotics. TD SYNNEX reported Q3 revenue of $21.6B, up 37.7% Y/Y, and forecasts Q4 revenue of $21.8B-$22.6B. The deal is subject to approvals.

mdm.com2 min
OCT 7
$TDMed

TD SYNNEX to Acquire Specialty Technology Distributor BlueStar

TD SYNNEX agreed to acquire BlueStar, a specialty tech distributor. The deal expands TD SYNNEX's capabilities in AIDC, operational tech, and mobility. Financial terms were not disclosed. The transaction is subject to regulatory approvals. Both companies will operate independently until closing. BlueStar specializes in technologies like RFID and point-of-sale systems. TD SYNNEX plans to combine BlueStar's expertise with its global platform.

citybiz.co2 min
OCT 7
$SNXHigh

TD SYNNEX to acquire specialty distributor BlueStar

TD SYNNEX (NYSE:SNX) agreed to acquire BlueStar, a specialty tech distributor. The deal is pending regulatory approval. BlueStar specializes in AIDC and related technologies. Financial terms were not disclosed. Both companies will operate independently until the transaction closes. SNX is a global distributor supporting 150,000+ customers across 100+ countries.

investing.com2 min